表紙
市場調査レポート

ドイツの血液凝固検査市場の新たなフロンティア:ビジネス面での課題、新規技術、競争環境

Germany Coagulation Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

発行 Venture Planning Group 商品コード 301132
出版日 ページ情報 英文 406 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。

Local License: 同一事業所内

Back to Top
ドイツの血液凝固検査市場の新たなフロンティア:ビジネス面での課題、新規技術、競争環境 Germany Coagulation Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape
出版日: ページ情報: 英文 406 Pages
概要

当レポートでは、ドイツにおける血液凝固検査の関連市場の最新動向や今後の市場機会について分析し、ドイツ市場の全体的な市場規模や将来動向(今後5年間分)、現在の診断技術の概要と今後の技術進歩・活用の見通し、今後の市場機会および解決すべき課題、現在/将来の市場参入企業のプロファイルなどを調査して、その結果を概略以下の構成でお届けします。

第1章 イントロダクション

第2章 世界市場と技術概要

  • 主な血液凝固検査(ルーチン検査・特別検査)
    • イントロダクション
    • APTT(活性化部分トロンボプラスチン時間)
    • α2抗プラズミン物質
    • 抗トロンビンIII
    • 出血時間
    • D-ダイマー
    • エタノール凝固テスト
    • ユーグロブリン溶解
    • 因子測定(全12種類)
    • フィブリン分解物
    • フィブリノゲン(線維素原)
    • ヘパリン
    • ヒルジン
    • 凝血能亢進および血栓症
    • リポたんぱく質A
    • プラスミン
    • プラスミノゲン
    • プラスミノゲン活性化因子阻害因子(PAI)
    • 血小板機能検査
    • 血小板凝集
    • プロテインC&S
    • プロトロンビンフラグメント1.2
    • プロトロンビン時間(PT)
    • レプチラーセ時間
    • トロンビン時間
    • t-PA(組織型プラスミノゲン活性化因子)
    • フォン・ヴィレブランド因子
  • 各種装置のレビュー
  • 主要な体外診断技術と潜在的な用途
    • 分子診断
    • 発色基質
    • モノクローナル抗体とポリクローナル抗体
    • 免疫学的検定
    • マイクロコンピュータ
    • オートメーション
    • ロボット工学
    • 人工知能
    • ドライケミストリー
    • バイオセンサー

第3章 ドイツ市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模・成長率、主要サプライヤーの売上高と市場シェア

第4章 主な製品開発機会

第5章 分散検査製品の設計基準

第6章 代替的な市場参入戦略

  • 内部開発
  • 協働事業協定
  • 大学との契約
  • 分散検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

第7章 潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 技術の限界
  • 特許保護
  • 規制による抑制
  • 分散検査市場の課題

第8章 競合企業の評価

  • Abbott
  • ADI/American Diagnostic
  • Axis-Shield
  • Alere/Biosite/Inverness
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago/Trinity Biotech
  • Grifols
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • ITC/Nexus Dx
  • Roche
  • Siemens
  • Sienco
  • シスメックス
  • Thermo Fischer
  • ZyCare/Alere

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPCO19963

VPGMarketResearch’s new report designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities and develop effective strategies for the German coagulation testing market during the next five years.

The report explores business and technological trends in the German coagulation testing market; provides estimates of the test volume, as well as sales and market shares for leading instrument and reagent competitors; compares features of major analyzers; profiles leading market players; analyzes potential applications of emerging technologies; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Rationale

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the German coagulation diagnostics practice during the next five years. New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

German Market Overview

- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers. Estimated universe of facilities performing coagulation tests. Five-year test volume and sales projections.

Business Opportunities and Strategic Recommendations

- Product development and business expansion opportunities with significant market appeal. “Ideal” product models with tentative prices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks.

Current and Emerging Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.

Sales and Market Share Analysis of Instrument and Reagent Suppliers

- Sales and market shares of major instrument and consumable manufactures.

Market Segmentation Analysis

- Comprehensive market segmentation analysis, including:

     - Hospitals      - Commercial/Private Laboratories

- Test volume forecasts for over 40 major procedures, by market segment.

Current and Emerging Products

- Review of established and new procedures.

- Comparison of automated and semi-automated analyzers marketed by Diagnostica Stago, Helena, IL, Roche, Siemens, Sysmex and other suppliers.

Technology Review

- Analysis of current and emerging technologies and their potential market applications.

- Comprehensive lists of companies developing or marketing new technologies and products by test.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative coagulation testing technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

- The companies analyzed in the report include:

     - Abbott      - ADI/American Diagnostica      - Alere/Biosite/Inverness      - Axis-Shield      - Beckman Coulter/Danaher      - Becton Dickinson      - Bio/Data      - Chrono-Log      - Corgenix Medical/Orgentec      - Diagnostica Stago/Trinity Biotech      - Grifols      - Helena Laboratories      - Hyphen BioMed      - Instrumentation Laboratory      - ITC/Nexus Dx      - Roche      - Siemens      - Sienco      - Sysmex      - Thermo Fisher      - ZyCare/Alere

Contains 406 pages and 38 tables

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

  • A. Major Routine and Special Coagulation Tests
    • 1. Introduction
    • 2. Activated Partial Thromboplastin Time (APTT)
    • 3. Alpha-2 Antiplasmin
    • 4. Antithrombin III
    • 5. Bleeding Time
    • 6. D-Dimer
    • 7. Ethanol Flocculation Test
    • 8. Euglobulin Lysis
    • 9. Factor Assays
      • a. Introduction
      • b. Factor II
      • c. Factor V/Factor V Leiden
      • d. Factor VII
      • e. Factor VIII
      • f. Factor IX
      • g. Factor IXa
      • h. Factor X (Stuart Factor)
      • i. Factor Xa
      • j. Factor XI
      • k. Factor XII
      • l. Factor XIII
    • 10. Fibrin Degradation Products
    • 11. Fibrinogen
    • 12. Heparin
    • 13. Hirudin
    • 14. Hypercoagulability and Thrombosis
    • 15. Lipoprotein a
    • 16. Plasmin
    • 17. Plasminogen
    • 18. Plasminogen Activator Inhibitor (PAI)
    • 19. Platelet Function Tests
    • 20. Platelet Aggregation
    • 21. Proteins C and S
    • 22. Prothrombin Fragment 1.2
    • 23. Prothrombin Time (PT)
    • 24. Reptilase Time
    • 25. Thrombin Time
    • 26. Tissue-Type Plasminogen Activator (t-PA)
    • 27. Von Willebrand's Factor
  • B. Instrumentation Review
  • C. Major in Vitro Diagnostic Technologies and Their Potential Applications
    • 1. Molecular Diagnostics
      • a. Technology Overview
      • b. Amplification Methods
      • c. Sequencing
      • d. Microarrays/Biochips
    • 2. Chromogenic Substrates
    • 3. Monoclonal and Polyclonal Antibodies
    • 4. Immunoassays
    • 5. Microcomputers
    • 6. Automation
    • 7. Robotics
    • 8. Artificial Intelligence
    • 9. Dry Chemistry
    • 10. Biosensors

III. German

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Instrument and Reagent Suppliers' Sales and Market Shares

IV. Major Product Development Opportunities

V. Design Criteria For Decentralized Testing Products

VI. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types Of Distributors
    • 7. Market Segmentation

VII. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VIII. Competitive Assessments

  • Abbott
  • ADI/American Diagnostic
  • Axis-Shield
  • Alere/Biosite/Inverness
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago/Trinity Biotech
  • Grifols
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • ITC/Nexus Dx
  • Roche
  • Siemens
  • Sienco
  • Sysmex
  • Thermo Fischer
  • ZyCare/Alere

List of Tables

  • Major Companies Developing or Marketing Activated Clotting Time Tests
  • Major Companies Developing or Marketing APTT Tests
  • Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
  • Major Companies Developing or Marketing Antithrombin III Tests
  • Major Companies Developing or Marketing Bleeding Time Tests
  • Major Companies Developing or Marketing D-dimer Tests
  • Major Companies Developing or Marketing Factor Assays
  • Major Companies Developing or Marketing Fibrin Degradation Product Tests
  • Major Companies Developing or Marketing Fibrinogen Tests
  • Major Companies Developing or Marketing Heparin Tests
  • Major Companies Developing or Marketing Plasmin Tests
  • Major Companies Developing or Marketing Plasminogen Tests
  • Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
  • Major Companies Developing or Marketing Platelet Aggregation Tests
  • Major Companies Developing or Marketing Protein C Tests
  • Major Companies Developing or Marketing Protein S Tests
  • Major Companies Developing or Marketing PT Tests
  • Major Companies Developing or Marketing Thrombin Time Tests
  • Major Companies Developing or Marketing TPA Tests
  • Major Companies Developing or Marketing Von Willebrand's Factor Tests
  • Executive Summary Table: Germany, Total Coagulation Diagnostics Market By Market Segment and Product Category
  • Germany, Laboratories Performing Coagulation Tests By Market Segment
  • Germany, Hospital Laboratories Performing Coagulation Tests By Bed Size
  • Germany, Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume
  • Germany, Hospital Laboratories Average Daily Test Volume
  • Germany, Commercial/Private Laboratories Average Daily Test Volume
  • Germany, Physician Offices/Group Practice Average Daily Test Volume
  • Germany, Total Coagulation Test Volume By Market Segment
  • Germany, All Market Segments Coagulation Test Volume
  • Germany, Hospital Laboratories Coagulation Test Volume
  • Germany, Commercial/Private Laboratories Coagulation Test Volume
  • Germany, Physician Offices/Group Practices Coagulation Test Volume
  • Germany, Coagulation Reagent Market By Market Segment
  • Germany, Major Suppliers of Coagulation Reagents, Estimated Sales and Market Shares
  • Germany, Coagulation Instrument Market By Market Segment
  • Germany, Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares
  • Germany, Total Coagulation Diagnostics Market By Product Category
  • Germany, Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares
Back to Top